Nick Zdenkowski

Professional Summary: Professor Nick Zdenkowski

Professor Nick Zdenkowski is a distinguished academic and medical professional affiliated with the University of Newcastle, Australia. With a career spanning clinical practice, research, and education, he has made significant contributions to the field of oncology, particularly in breast cancer treatment and research. Below is a detailed overview of his academic and professional journey based on publicly available information.

Academic Background and Degrees

Professor Zdenkowski holds advanced qualifications in medicine and research, reflecting his expertise in oncology. While specific details of his degrees (e.g., MBBS, PhD) are not fully itemized in public sources, his professional standing and contributions indicate a robust academic foundation in medical sciences, likely obtained from prestigious institutions in Australia or internationally.

Research Specializations and Academic Interests

Professor Zdenkowski specializes in medical oncology, with a primary focus on breast cancer. His research interests include:

• Clinical trials for breast cancer therapies
• Personalized medicine and decision-making in cancer treatment
• Patient-centered care and shared decision-making frameworks

His work often bridges clinical practice with research, aiming to improve patient outcomes through evidence-based approaches.

Career History and Appointments

Professor Zdenkowski has held several key positions in both clinical and academic settings. Notable appointments include:

• Conjoint Professor, School of Medicine and Public Health, University of Newcastle, Australia
• Medical Oncologist, specializing in breast cancer, at various hospitals and cancer centers in New South Wales
• Active involvement in clinical research roles with organizations such as Breast Cancer Trials (formerly Australia and New Zealand Breast Cancer Trials Group)

Major Awards, Fellowships, and Honors

While specific awards and fellowships are not extensively documented in public sources, Professor Zdenkowski’s leadership in clinical trials and oncology research suggests recognition within his field. His contributions to breast cancer research have likely earned him accolades or nominations for prestigious awards in medical research and patient care.

Key Publications

Professor Zdenkowski has authored and co-authored numerous peer-reviewed articles and papers, particularly in the domain of breast cancer treatment and decision-making. Some notable publications include:

• Zdenkowski, N., et al. (2016). 'Systematic review of decision aids for patients making a decision about treatment for early breast cancer.' Breast Cancer Research and Treatment.
• Zdenkowski, N., et al. (2019). 'Shared decision-making in breast cancer: A systematic review and meta-analysis.' Breast Cancer Research and Treatment.
• Contributions to clinical trial outcomes published in journals such as The Lancet Oncology and Journal of Clinical Oncology (specific titles and years may vary based on trial reporting).

These works highlight his focus on improving therapeutic decision-making and patient outcomes in oncology.

Influence and Impact on Academic Field

Professor Zdenkowski has had a notable impact on the field of medical oncology, particularly through his contributions to breast cancer research. His work on decision aids and shared decision-making has influenced clinical practices, helping to empower patients and clinicians with tools for better treatment choices. His involvement in large-scale clinical trials has also contributed to advancements in evidence-based therapies, shaping guidelines for breast cancer management in Australia and beyond.

Public Lectures, Committee Roles, and Editorial Contributions

Professor Zdenkowski is actively involved in the academic and clinical community. Publicly available information indicates:

• Regular participation in national and international conferences on oncology and breast cancer, often presenting research findings or leading discussions.
• Membership and leadership roles in committees associated with Breast Cancer Trials, contributing to the design and oversight of clinical studies.
• Potential editorial contributions to medical journals or peer-review activities, though specific roles are not widely documented in public sources.

His engagement in these areas underscores his commitment to advancing both research and education in oncology.